Ml216-induced blm helicase inhibition sensitizes pca cells to the dna-crosslinking agent cisplatin

HIGHLIGHTS

• who: Xiao-Yan Ma and collaborators from the College Life Sciences, Guizhou University, Guiyang, China have published the Article: ML216-Induced BLM Helicase Inhibition Sensitizes PCa Cells to the DNA-Crosslinking Agent Cisplatin, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of /2022/
• what: The authors examined the combined anti-tumor effect of the inhibitors of BLM and the DNA-crosslinking agent CDDP in PCa cells.
• how: The authors obtained similar results through IF experiments . WB analysis of the ML216-CDDP combination`s induction u03b3H2AX in PC3 cells at 48 h . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.